Literature DB >> 24185124

Aberrant expression of multiple T antigens: CD4, CD5, and CD8 on diffuse large B-cell lymphoma.

Nikhil A Sangle1, Rodney R Miles, Todd W Kelley, Sherrie L Perkins.   

Abstract

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. Aberrant expression of T antigens (exclusive of CD5) in DLBCL has been described in the literature; however, coexpression of 2 or more T antigens is rare. We report a case with a well-established diagnosis of DLBCL, coexpressing 3 T-cell antigens, CD4, CD5, and CD8. Although the clinical significance of T antigen coexpression in DLBCL is unclear, it is important to be aware of such phenotypic plasticity to ensure accurate diagnoses are made. The expression of multiple T-cell antigens may introduce diagnostic confusion and make subclassification of a lymphoma using World Health Organization criteria difficult.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24185124     DOI: 10.1097/PAI.0b013e31829cc54c

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  3 in total

1.  Aberrant expression of multiple T cell markers on diffuse large B cell lymphoma: a case report.

Authors:  Anurag Mehta; Prerna Chadha; Poojan Agarwal; Sunil Pasricha
Journal:  J Egypt Natl Canc Inst       Date:  2021-06-15

2.  Identification of super enhancer-associated key genes for prognosis of germinal center B-cell type diffuse large B-cell lymphoma by integrated analysis.

Authors:  Xi Li; Yan Duan; Yuxia Hao
Journal:  BMC Med Genomics       Date:  2021-03-04       Impact factor: 3.063

3.  Prognostic Role of Tumor Microenvironment in DLBCL and Relation to Patients' Clinical Outcome: A Clinical and Immunohistochemical Study.

Authors:  Doaa Shams-Deen Ghorab; Ahmed Mohamed Helaly; Hoda Saleh El Mahdi; Moawiah Khatatbeh; Afaf Taha Ibrahiem
Journal:  Anal Cell Pathol (Amst)       Date:  2022-01-17       Impact factor: 2.916

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.